NIH Prior Agreement Required for $500,000+ Direct Costs
For applications requesting $500,000 or more direct costs for any year, applicants must seek agreement to accept assignment from Institute/Center staff at least 6 weeks prior to the anticipated submission of any application. See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-004.html. This policy does not apply to applications submitted in response to RFAs or in response to other Announcements that include specific budgetary limits.
DEADLINE EXTENDED TO SATURDAY, MAY 11th at noon: The OK Catalyst Researchers
program provides training and resources on how to start a business for graduate students, post-docs, and faculty conducting research in STEM-related fields from Oklahoma universities. There will be lectures from subject matter experts every week and a chance to win up to $3,000. Applicants
should have an interest in entrepreneurship and product development and propose an innovative project in a STEM-related field. Compete to win up to $3,000. For complete information see the attached document.
NIH/NIGMS IDeA Central Region Conference – Registration deadline May 15!
The 2019 IDeA Central Region Conference will be held June 12 - 14, 2019 at the Sheraton Oklahoma City Downtown Hotel. The conference will highlight IDeA research programs (COBRE, INBRE, IDeA-CTR, STTR and ISPCTN) and will feature thematic breakout sessions, a poster session for both faculty and students, student research presentations, NIH program officers, and opportunities for networking and collaboration. Faculty and students are invited to attend. The IDeA central region states include Oklahoma, Kansas, Nebraska, North Dakota and South Dakota.
Conference website: https://okinbre.ouhsc.edu/IDeA-Regional-Conference-2019
Registration: May 15, 2019
Abstract Submission: May 15, 2019
Hotel reservations: May 17, 2019
University of Oklahoma is hosting the national Small Business Administration SBIR Road Tour on May 20th at the Oklahoma Hall of Fame. While this event is focused on the Small Business Innovation Research (SBIR/STTR) program, there will be a lot of opportunity for one-on-one meetings with different
program managers and many of the program managers may also be involved with traditional academic R&D funding. Please see the attached document for additional information.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/SBIR Road Tour Agenda.docx?ver=2019-04-29-073012-930
One (and Maybe One More) Then Start Again New – Understanding NIH Resubmission Rules It’s important to understand the Resubmission process. For additional information please see the attached document and/or go to:
On May 1, 2019, Adobe Reader Version 9 will no longer be compatible for use with Grants.gov Workspace PDF forms.
This is a reminder to keep your (free) Adobe Acrobat Reader software up-to-date. For more information on compatible versions of Adobe Reader software for use with Grants.gov, please review our Adobe Software Compatibility page. There, you can verify the compatibility of your version of
Adobe Reader for use with Grants.gov Workspace PDF forms. For additional information go to:
NEW IRB PROTOCOL OUTLINE & REVISED CONSENT TEMPLATE AVAILABLE:
- In case you missed this announcement on the HRPP website, a NEW and improved Protocol Outline was published on 3/12/2019.
This outline should be used when developing and writing investigator-initiated protocols. Please discard the old outline version dated 2009.
- CONSENT TEMPLATE 701-G UPDATED 4/19/2019: This revised consent template includes a NEW and REQUIRED section for participant rights over
personal data and information. Please discard all previous 701-G templates you may have saved and use the new version dated 04/19/2019.
*** Researchers may access the new Protocol Outline and 701-G Consent Template on the HRPP website in the Researcher’s Toolkit section.
IMPORTANT: The HRPP website is our PRIMARY location for posting announcements and updated templates. So while you’re there, bookmark our website and check back often so you can stay up-to-date with current events and changes that may affect your research submissions to the IRB.
Request for Information (RFI) Regarding Tissue Source Options for Generating Human Immune System (HIS) Mice (NOT-OD-19-093)
Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NOT-OD-19-106)
Request for Information (RFI): Inviting Comments and Suggestions for the Development of the NIA Longitudinal Rat Resource to Study Neural and Behavioral Trajectories of Successful Cognitive Aging (NOT-AG-19-017)
Notice of Correction to NOT-AG-19-007, "Notice of Special Interest: High-Priority Research Topics for PAR-19-071" (NOT-AG-19-019)
Notice of Intent to Publish: Funding Opportunity Announcement for Human Immune-Representing Oncology Models for Immuno-Oncology Research (R33 Clinical Trial Optional) (NOT-CA-19-047)
Notice of NIDCR's Participation in PAR-19-193 "Microbial-based Cancer Therapy-Bugs as Drugs (R01- Clinical Trial Not Allowed)" (NOT-DE-19-006)
Notice of NIDCR's Participation in PAR-19-194 "Microbial-based Cancer Therapy-Bugs as Drugs (R21- Clinical Trial Not Allowed)" (NOT-DE-19-007)
Notice of Information: NIH In-Kind Participation in Belmont Forum Collaborative Research Action (CRA) on Climate, Environment and Health (CEH) (NOT-ES-19-014)
Notice of Change in Candidate Eligibility for PAR-18-726 "NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)" (NOT-EY-19-026)
Notice of Change in the NEI K23 Eligibility Requirements (NOT-EY-19-027)
Notice of Change in the NEI K08 Eligibility Requirements (NOT-EY-19-028)
Request for Information: Research Plan on Rehabilitation (NOT-HD-19-006)
Notice of Change to Key Date(s) for RFA-HD-20-004 "Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)" (NOT-HD-19-014)
Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-005 "Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 CT Optional)" (NOT-HL-19-696)
Notice of Clarification: Application Types for PA-18-794, AHRQ Small Research Grant Program (R03) (NOT-HS-19-014)
Notice of Special Interest to Highlight High Priority Research Opportunities on Suicide Prevention Crisis Services (NOT-MH-19-025)
Please Note: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (RFA-AR-20-001) Deadline August 5, 2019
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (RFA-AR-20-002) Deadline August 5, 2019
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed) (RFA-AR-20-003) – Deadline July 10, 2019
"HEAL Initiative: Limited Competition: Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) to Reduce Opioid Prescribing (U24 Clinical Trial Not Allowed)” (RFA-AT-19-011) – Deadline July 8, 2019
Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed) (RFA-DA-20-005) – August 15, 2019
Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional (RFA-FD-19-016) Deadline June 25, 2019
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) (PAR-19-258) – Deadline July 22, 2019 and July 22, 2020
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) (PAR-19-259) Deadline September 25, 2019
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) (PAR-19-260) – Deadline June 16, 2019 and October 16, 2019
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) (PAR-19-261) Deadline July 1, 2019 and December 16, 2019
OTHER FEDERAL DEADLINES
Department of Defense (DOD) – Peer Reviewed Cancer Research Program (PRCRP) – Career Development Award Required PreApplication due August 21, 2019 and Application due September 11, 2019 https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=206300
DOD – PRCRP – Horizon Award – Required PreApplication due August 21, 2019 and Application due September 11, 2019
DOD – PRCRP – Idea Award with Special Focus - Required PreApplication due May 22, 2019 and Application due September 11, 2019
DOD – PRCRP – Impact Award – Required PreApplication due May 22, 2019 and Application due September 11, 2019
DOD – PRCRP – Translational Team Science Award – Required PreApplication due May 22, 2019 and Application due September 11, 2019
DOD – Tick-Borne Disease Research Program (TBDRP) – Career Development Award – Required PreApplication due May 22, 2019 and Application due August 22, 2019
DOD – TBDRP – Idea Award – Required PreApplication due May 22, 2019 and Application due August 22, 2019
DOD – TBDRP – Investigator-Initiated Research Award – Required PreApplication due May 22, 2019 and Application due August 22, 2019
DOD – Tuberous Sclerosis Complex Research Program (TSCRP) – Exploration Hypothesis Development Award Required PreApplication due July 9, 2019 and Application due July 25, 2019
DOD – TSCRP – Idea Development Award – Required PreApplication due July 9, 2019 and Application due July 25, 2019
DOD – TSCRP – Clinical Translational Research Award – Required PreApplication due July 9, 2019 and Application due July 25, 2019